164 related articles for article (PubMed ID: 30204515)
1. Development of a Pediatric Goal-Centered Upper Limb Spasticity Home Exercise Therapy Program for Use in a Phase-III Trial of Abobotulinumtoxina (Dysport
Shierk A; Jiménez-Moreno AC; Roberts H; Ackerman-Laufer S; Backer G; Bard-Pondarre R; Cekmece C; Pyrzanowska W; Vilain C; Delgado MR
Phys Occup Ther Pediatr; 2019; 39(2):124-135. PubMed ID: 30204515
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study.
Delgado MR; Tilton A; Carranza-Del Río J; Dursun N; Bonikowski M; Aydin R; Maciag-Tymecka I; Oleszek J; Dabrowski E; Grandoulier AS; Picaut P;
Dev Med Child Neurol; 2021 May; 63(5):592-600. PubMed ID: 33206382
[TBL] [Abstract][Full Text] [Related]
3. Goal Attainment after Treatment with Abobotulinumtoxina and a Tailored Home Therapy Programme in Children with Upper Limb Spasticity: Descriptive, Exploratory Analysis of a Large Randomized, Controlled Study.
Carranza-Del Río J; Dursun N; Cekmece C; Bonikowski M; Pyrzanowska W; Dabrowski E; Tilton A; Oleszek J; Volteau M; Page S; Shierk A; Delgado MR
J Rehabil Med; 2022 Dec; 54():jrm00349. PubMed ID: 36306168
[TBL] [Abstract][Full Text] [Related]
4. AbobotulinumtoxinA Efficacy and Safety in Children With Equinus Foot Previously Treated With Botulinum Toxin.
Dabrowski E; Bonikowski M; Gormley M; Volteau M; Picaut P; Delgado MR
Pediatr Neurol; 2018 May; 82():44-49. PubMed ID: 29625849
[TBL] [Abstract][Full Text] [Related]
5. More than a black box of rehabilitation: Characterizing therapy programmes following botulinum toxin injections for spasticity in adults with stroke.
Demetrios M; Brand C; Louie J; Khan F
J Rehabil Med; 2016 Apr; 48(5):426-34. PubMed ID: 27097568
[TBL] [Abstract][Full Text] [Related]
6. Early AbobotulinumtoxinA (Dysport
Rosales RL; Balcaitiene J; Berard H; Maisonobe P; Goh KJ; Kumthornthip W; Mazlan M; Latif LA; Delos Santos MMD; Chotiyarnwong C; Tanvijit P; Nuez O; Kong KH
Toxins (Basel); 2018 Jun; 10(7):. PubMed ID: 29933562
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of upper limb botulimun toxin versus placebo injection, combined with physiotherapy, in children with hemiplegia.
Ferrari A; Maoret AR; Muzzini S; Alboresi S; Lombardi F; Sgandurra G; Paolicelli PB; Sicola E; Cioni G
Res Dev Disabil; 2014 Oct; 35(10):2505-13. PubMed ID: 24995688
[TBL] [Abstract][Full Text] [Related]
8. AbobotulinumtoxinA: A Review in Pediatric Lower Limb Spasticity.
Syed YY
Paediatr Drugs; 2017 Aug; 19(4):367-373. PubMed ID: 28623614
[TBL] [Abstract][Full Text] [Related]
9. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
10. Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity impairments in unilateral Cerebral Palsy: an explorative study.
Speth L; Janssen-Potten Y; Leffers P; Rameckers E; Defesche A; Winkens B; Becher J; Smeets R; Vles JS
Eur J Paediatr Neurol; 2015 May; 19(3):337-48. PubMed ID: 25661064
[TBL] [Abstract][Full Text] [Related]
11. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).
Turner-Stokes L; Ashford S; Jacinto J; Maisonobe P; Balcaitiene J; Fheodoroff K
BMJ Open; 2016 Jun; 6(6):e011157. PubMed ID: 27315835
[TBL] [Abstract][Full Text] [Related]
12. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Davies L; McCrory P; Hughes A
J Rehabil Med; 2010 Jan; 42(1):81-9. PubMed ID: 20111849
[TBL] [Abstract][Full Text] [Related]
13. AbobotulinumtoxinA (Dysport
Tilton A; Russman B; Aydin R; Dincer U; Escobar RG; Kutlay S; Lipczyk Z; Velez JC; Grandoulier AS; Tse A; Picaut P; Delgado MR
J Child Neurol; 2017 Apr; 32(5):482-487. PubMed ID: 28068857
[TBL] [Abstract][Full Text] [Related]
14. Rationale for using botulinum toxin A as an adjunct to upper limb rehabilitation in children with cerebral palsy.
Hoare B
J Child Neurol; 2014 Aug; 29(8):1066-76. PubMed ID: 24820338
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Botulinum Toxin Type A Injection Followed by Rehabilitation in Cases of Cerebral Palsy With Upper Extremity Involvement.
Karaca B; Ünlü E; Köse G; Gönen E; Çakcı A
J Child Neurol; 2016 Mar; 31(3):357-63. PubMed ID: 26239492
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Repeat Open-Label AbobotulinumtoxinA Treatment in Pediatric Cerebral Palsy.
Delgado MR; Bonikowski M; Carranza J; Dabrowski E; Matthews D; Russman B; Tilton A; Velez JC; Grandoulier AS; Picaut P
J Child Neurol; 2017 Nov; 32(13):1058-1064. PubMed ID: 28914131
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness and impact on quality of life of abobotulinumtoxinA and onabotulinumtoxinA in the treatment of children with lower limb spasticity in Canada.
Johnston K; Danchenko N; Hansen R; Dinet J; Liovas A; Armstrong A; Bains S; Sullivan SD
J Med Econ; 2020 Jun; 23(6):631-640. PubMed ID: 31985313
[No Abstract] [Full Text] [Related]
18. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
[TBL] [Abstract][Full Text] [Related]
19. Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
Gracies JM; O'Dell M; Vecchio M; Hedera P; Kocer S; Rudzinska-Bar M; Rubin B; Timerbaeva SL; Lusakowska A; Boyer FC; Grandoulier AS; Vilain C; Picaut P;
Muscle Nerve; 2018 Feb; 57(2):245-254. PubMed ID: 28590525
[TBL] [Abstract][Full Text] [Related]
20. Dose-Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study.
O'Dell MW; Brashear A; Jech R; Lejeune T; Marque P; Bensmail D; Ayyoub Z; Simpson DM; Volteau M; Vilain C; Picaut P; Gracies JM
PM R; 2018 Jan; 10(1):1-10. PubMed ID: 28634000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
